Capula Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
240
+49
| +26% | +$25.7K | ﹤0.01% | 167 |
|
|
2025
Q1 | $121K | Buy |
+191
| New | +$121K | ﹤0.01% | 307 |
|
|
2024
Q4 | – | Sell |
-34
| Closed | -$35.7K | – | 366 |
|
|
2024
Q3 | $35.7K | Buy |
+34
| New | +$35.7K | ﹤0.01% | 277 |
|
|
2024
Q2 | – | Sell |
-62
| Closed | -$59.7K | – | 463 |
|
|
2024
Q1 | $59.7K | Sell |
62
-431
| -87% | -$415K | ﹤0.01% | 365 |
|
|
2023
Q4 | $433K | Sell |
493
-39
| -7% | -$34.3K | 0.02% | 100 |
|
|
2023
Q3 | $438K | Buy |
+532
| New | +$438K | 0.01% | 226 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 556 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 551 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 343 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 140 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 111 |
|
|
2021
Q2 | – | Sell |
-9,286
| Closed | -$4.39M | – | 498 |
|
|
2021
Q1 | $4.39M | Buy |
+9,286
| New | +$4.39M | 0.09% | 24 |
|